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Abstract
Background: Antibiotic resistance is a major problem for human health. Multidrug resistance efflux pumps, especially
those of the Resistance-Nodulation-Cell Division (RND) family, are major contributors to high-level antibiotic resistance
in Gram-negative bacteria. Most bacterial genomes contain several copies of the different classes of multidrug
resistance efflux pumps. Gene duplication and gain of function by the duplicate copies of multidrug resistance
efflux pump genes plays a key role in the expansion and diversification of drug-resistance mechanisms.
Results: We used two members of the Burkholderia RND superfamily as models to understand how duplication
events affect the antibiotic resistance of these strains. First, we analyzed the conservation and distribution of
these two RND systems and their regulators across the Burkholderia genus. Through genetic manipulations, we
identified both the exact substrate range of these transporters and their eventual interchangeability. We also
performed a directed evolution experiment, combined with next generation sequencing, to evaluate the role of
antibiotics in the activation of the expression of these systems. Together, our results indicate that the first step to
diversify the functions of these pumps arises from changes in their regulation (subfunctionalization) instead of
functional mutations. Further, these pumps could rewire their regulation to respond to antibiotics, thus maintaining
high genomic plasticity.
Conclusions: Studying the regulatory network that controls the expression of the RND pumps will help understand
and eventually control the development and expansion of drug resistance.
Keywords: Subfunctionalization, Burkholderia, Antibiotic resistance, RND
Background
Antibiotic resistance is a major challenge for the twenty-
first century [1]. A large number of bacteria resistant to
multiple classes of antibiotics has emerged worldwide,
making treatment difficult [2, 3]. Multidrug antibiotic re-
sistance (MDR) is a highly attractive model to study the
evolution of gene function since hypermutation, com-
plex interrelationships between drug resistance and fit-
ness, compensatory evolution, and epistasis affect how
resistance evolves and spread [4]. Although different
mechanisms influence the emergence of a MDR pheno-
type, high-level intrinsic MDR, particularly in Gram-
negative bacteria, stems from the combined action of ef-
flux pumps and adaptive modifications of the cell enve-
lope [2].
The structural components of MDR efflux pumps
(MDR EP), usually chromosomally encoded, are evolu-
tionarily conserved within species [reviewed in [3]]. In-
deed, MDR EP are ancient elements in bacterial genomes,
suggesting that their functions predate the resistance to
antibiotics during the treatment of human infections [5].
Bacterial genomes often contain multiple copies of differ-
ent MDR EP classes, which have arisen by gene duplica-
tions [6, 7]. The importance of gene duplication in driving
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expansion and diversification of drug-resistance mecha-
nisms and its role as an adaptive response to antibiotic
treatment are well-known [8–10]. In general, extra gene
copies after duplication events are redundant and free
from selection pressure, as they do not add anything to
the organism’s capacity to perform the original (dupli-
cated) function [11]. The fate of paralogous copies is
strongly debated and no single model can include all the
possible alternative scenarios [11]. Duplicated genes rarely
exhibit de novo functions (neofunctionalization); more
commonly, the functions of the original gene(s) are split
into multiple functions among the duplicate genes (sub-
functionalization) [12]. The split into subfunctions among
the different paralogs may occur when the functions of the
original gene(s), which were previously under unified gen-
etic control, acquire their own independent regulation [13].
Among MDR efflux pumps, the Resistance-Nodulation-
Cell Division (RND) superfamily is particularly intriguing
[14]. Members of this superfamily of proton/drug antipor-
ters located in the inner membrane have several roles
including bacterial virulence, quorum sensing, plant–bac-
teria interactions, and detoxification of metabolic interme-
diates and toxic compounds, such as heavy metals,
solvents, or antimicrobials [15]. The regulation of RNDs
depends on global and/or local regulators, resulting in a
multilayered control of gene expression in response to
specific stimuli. The high efficiency of RNDs in extruding
substrates is due to their associations with outer mem-
brane channel (OMP) and periplasmic membrane fusion
(MFP) proteins. These tripartite complexes extrude mole-
cules to the extracellular milieu preventing their accumu-
lation in the periplasmic space [16]. The genes encoding
the three protein components (RND, OMP, and MFP) are
often organized in an operon and several different RND
operons may be embedded in the same genome [3, 17].
These efflux pumps have been mostly studied in Gram-
negative bacteria, such as Pseudomonas aeruginosa,
Escherichia coli, and Acinetobacter baumannii [3]. Re-
cently, attention has also been focused on RND systems of
other pathogenic bacteria, such as Burkholderia species
[18], and more specifically, the Burkholderia cepacia com-
plex (Bcc) [19]. Bcc bacteria have been extensively investi-
gated concerning their genome organization and the
presence of several copies of MDR systems, especially the
RND superfamily [20, 21].
Although rampant gene duplication played a key role
in shaping this gene family, the tempo and mode of this
process remains unknown. The genome of the model
strain B. cenocepacia J2315 harbors several genes encod-
ing RND proteins of different families [18, 20–22]. Two
RND copies (RND 2 and 4) have been the focus of our
attention since they provide a model to investigate the
evolution of paralogs that are functionally distinct but
with a high degree of sequence similarity. Previously, we
have shown that the RND 2 coding gene is present only
in some Bcc species, and a phylogenetic analysis re-
vealed that the amino acid sequences of RND 2 and
RND 4 proteins cluster together [20]. Despite this high
degree of sequence similarity, only the RND 4 protein
plays a key role in the antibiotic resistance of B. cenoce-
pacia J2315, since a deletion of the entire RND 4 operon
reduces the intrinsic MDR antibiotic resistance of the
mutant strain [23, 24]. Further, RND 4 appeared to be
particularly important for antibiotic resistance of plank-
tonic bacteria, but less relevant for resistance in biofilm
bacteria [25]. RND 4 also contributes to resistance to the
biocide chlorhexidine [26] and the 2-thiopyridine anti-
tubercular derivative, which is also effective against B.
cenocepacia [27]. This pump is also associated with the
modulation of some virulence factors (motility, biofilm
formation, chemotaxis and quorum sensing) [24]. A
proteomic analysis comparing the parental strain and
the deletion mutant suggests a more general role for
RND 4 in the physiology of B. cenocepacia cells [28].
Conversely, the Burkholderia RND 2 protein is not
expressed during growth on LB medium, and its role in
antibiotic resistance can only be revealed when overex-
pressed in E. coli [29] .
In this study, we provide computational and experi-
mental evidence supporting an evolutionary model on
the functional diversification of these two RND super-
family members in Burkholderia spp., providing a frame-
work to understand how these events could modulate
antibiotic resistance.
Results
Operon structure, comparative genomics and phylogeny
The RND 2 operon is located on B. cenocepacia J2315
chromosome 3. It consists of three genes organized in the
following order: BCAS0766 (QU43_RS72495, 1239 bp),
BCAS0765 (QU43_RS72490, 3192 bp), and BCAS0764
(QU43_RS72485, 1503 bp), encoding the MFP, RND per-
mease, and OMP proteins, respectively. A LysR family tran-
scriptional regulator (BCAS0767; QU43_RS72500, 881 bp)
is located upstream of BCAS0766 and oriented in the same
direction (Fig. 1a). Another gene, encoding an AraC family
transcriptional regulator (BCAS0768; QU43_RS72510,
983 bp) is present upstream of the LysR regulator coding
gene, but oriented in the opposite direction (Fig. 1a). The
RND 4 operon is located on chromosome 1 and spans
three genes: BCAL2822 (QU43_RS50725, 1275 bp),
BCAL2821 (QU43_RS50720, 3201 bp), and BCAL2820
(QU43_RS50715, 1524 bp) encoding the MFP, RND per-
mease, and OMP proteins, respectively. Thus, the RND 2
and RND 4 operons share identical gene organization. A
gene encoding a TetR family transcriptional regulator
(BCAL2823; QU43_RS50730, 641 bp), found upstream of
BCAL2822, is oriented in the opposite direction (Fig. 1a).
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The degree of identity/similarity between the two operons
is 92%, 87%, 95% of identity at the nucleotide level, with
90%, 85%, 96% identity and 93%, 91%, 96% similarity at
the amino acid level when comparing the MFP, RND and
OMP genes and proteins, respectively. The degree of
DNA and amino acid sequence identity/similarity between
the genes/proteins of the two operons (Fig. 1a) and the
identical gene order strongly suggests these operons arose
from a recent operon duplication event. No major
evidence of purifying selection was found, as for al-
most all the pairwise comparisons among the RND,
MFP, and OMP sequences, the dN/dS ratio was lower
than 1 (Additional file 1 and Additional file 2).
A comparative genome analysis was performed on 797
Burkholderia genomes to evaluate the presence, distribu-
tion and conservation of RND 2 and RND 4 operons.
RND 2 and 4 coding genes were found in 47 and 689 of
the genomes analysed, respectively. Then the presence
of the other two genes (mfp and omp) forming the op-
erons was evaluated: the intact RND 2 operon occurred
in 33 genomes, while the intact RND 4 operon was
present in 472 (Additional file 3). The lack of the RND
genes (or of the entire operons) in some strains could be
due to the poor quality of the corresponding assemblies
(draft genomes). In these genomes, operon fragments
were found in contig boundaries. Therefore, incomplete
operons were excluded from the downstream analysis.
All genomes possessing the RND 2 operon were from
Bcc bacterial species, but not all Bcc species harbor this
operon. However, except for a few cases, the RND 2 op-
eron co-occurred with RND 4 (Additional file 3). The
phylogenetic tree of Fig. 1b (redrawn from the tree re-
ported in De Smet et al. [19]) indicates the species in
which a copy of the RND 2 operon was found. Accord-
ing to the phylogenetic distribution of RND4 and RND2
operons, the putative duplication event involving RND 4
B. contaminans LMG 23361
B. lata LMG 22485
B. metallica LMG 24068
B. cepacia LMG 1222
B. cenocepacia IIIC LMG 19230
B. arboris LMG 24066
B. pyrrocinia LMG 14921
B. stabilis LMG 14294
B. seminalis LMG 24067
B. cenocepacia IIID LMG 21462
B. cenocepacia IIIB LMG 18830
B. cenocepacia IIIA LMG 16656
B. anthina LMG 20980
B. ambifaria LMG 19182
B. diffusa LMG 24065
B. vietnamensis LMG 10929
B. latens LMG 24064
B. territorii LMG 29158
B. pseudomultivorans LMG 26883
B. multivorans LMG 13010
B. dolosa LMG 18943
B. ubonensis LMG 20358
B. stagnalis LMG 28156
B. fungorum LMG 16225
*
*
*
Putative RND2 operon 
duplication origin
Chr. 3, RND2 operon
Chr. 1, RND4 operon
94% 89% 99%
AraC HP LysR MFP RND OMP
MFP RND OMPTetR
b
a
B. cenocepacia J2315
860.000865.000
3.095.000 3.100.000
Fig. 1 RND 2 and 4 operon structures and hypothetical point of operon duplication. a) Schematic representation of RND 2 and 4 operon structures in
B. cenocepacia J2315 genome. RND 2 operon: MFP coding gene (BCAS0766 = QU43_RS72495, 1239 bp), RND coding gene (BCAS0765 = QU43_RS72490,
3192 bp), OMP coding gene (BCAS0764 = QU43_RS72485, 1503 bp), LysR family transcriptional regulator (BCAS0767 = QU43_RS72500, 881 bp) and AraC
family transcriptional regulator (BCAS0768 = QU43_RS72510, 983 bp). HP: hypothetical protein. RND 4 operon: MFP coding gene (BCAL2822 = QU43_
RS50725, 1275 bp), RND coding gene (BCAL2821 = QU43_RS50720, 3201 bp), OMP coding gene (BCAL2820 = QU43_RS50715, 1524 bp), TetR family
transcriptional regulator (BCAL2823 = QU43_RS50730, 641 bp). The percentages given are the degree of identity between the two operons at the
nucleotide level. b) Schematic reconstruction of the phylogenetic tree reported in [19]: black triangle = RND 2 operon found in at least one strain
belonging to the associated species; black circle = presence of AraC and LysR regulators coding genes associated with the operon; * = no genome
belonging to this species is available
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and leading to RND 2 can be mapped inside the Bcc
group (Fig. 1b).
The conservation of the genes encoding regulatory
proteins associated with the RND 2 and RND 4 operons
in B. cenocepacia J2315 was also investigated. A gene en-
coding a TetR family transcriptional regulator was al-
ways associated with the RND 4 operons identified
(Additional file 3). LysR- and AraC-like transcriptional
regulator genes present upstream of the J2315 RND 2
operon were also associated with all the RND 2 operons
identified, and in the same order and orientation, except
for B. diffusa (Fig. 1b) (Additional file 3). The RND 4
promoter regions were highly conserved among different
strains and divergent from those of RND 2. The RND 2
promoter regions were also conserved among them-
selves, with the exception of B. diffusa (data not shown).
In both cases, conserved motifs putatively recognized by
regulatory proteins, were identified (Additional file 4).
Extra copies of the RND 2 operon can functionally replace
the RND 4 operon
To assess the role of the two RND operons in antibiotic
resistance and whether the RND 2 operon can function-
ally substitute RND 4, the B. cenocepacia J2315 RND 2
and RND 4 operons and their own promoter regions
were cloned and inserted into pSCrhaB2 [30], giving rise
to two recombinant plasmids (pEP_RND2_operon and
pEP_RND4_operon, respectively) (Table 1). These plas-
mids were introduced in the parental J2315 strain and in
a deletion mutant lacking the RND 4 operon (strain D4,
Table 1). The antibiotic resistance profile of these strains
was investigated by determining the Minimal Inhibitory
Concentration (MIC) values of 14 antibiotics belonging
to different classes. As a control, the MICs for a RND 2
operon deletion mutant were determined, and the same
results were obtained as for J2315 (data not shown). The
D4 strain was more sensitive than the parental J2315 to
fluoroquinolones, chloramphenicol, tetracycline, rifampi-
cin and novobiocin (Table 2), as previously reported [23,
24]. The other antibiotics tested are not substrates of
RND 4 efflux pumps. As expected, the MIC values of
D4(pEP_RND4_operon), in which the RND 4 pumps is
restored, were identical to those of J2315 (except for
levofloxacin, where the complementation of the RND 4
deletion was only partial). These results confirm that the
reduction in MIC values was due to the absence of the
RND 4 operon. The D4(pEP_RND2_operon) strain,
which expresses a plasmid encoded RND 2 pump,
showed an identical MIC profile as that of J2315 for cip-
rofloxacin and norfloxacin, a partial complementation
for levofloxacin, sparfloxacin, tetracycline, rifampicin
and novobiocin, and a MIC slightly higher for nalidixic
acid and chloramphenicol. These results suggest that the
RND 2 operon can complement the RND 4 deletion
(although to a lesser extent for some antibiotics) despite
not being able to carry out this function in the parental
strain. The MIC values of J2315(pEP_RND2_operon)
strain are not higher than those of J2315, while those of
J2315(pEP_RND4_operon) are in some cases slightly
higher, showing that additional copies of the two op-
erons do not significantly increase the MIC values of the
parental strain.
Native RND 2 is very poorly expressed in the D4 strain
The previous results indicate that extra copies of the
RND 2 operon can functionally replace the RND 4 op-
eron in the D4 deletion mutant by restoring resistance
to some antibiotics. This raised the question of why the
native RND 2 operon failed to complement the D4 mu-
tation in vivo. To address this question, we investigated
the expression of the RND 2 and RND 4 efflux protein
genes by qRT-PCR in the presence of nalidixic acid, one
of the common substrates of both pumps. In B. cenoce-
pacia J2315, the estimated quantity of mRNA of RND 2
was about 100 times lower than that of RND 4 [3·10−7
and 3·10−5 normalized copies respectively (quantity
mean normalized on the quantity mean of the 16S rRNA
coding gene)], while no RND 4 operon expression was
detected in the D4 mutant (Fig. 2). Further, the copy
number of RND 2 mRNA remained low also in the D4
mutant strain (1·10−7 normalized copies), suggesting that
the loss of RND 4 was not a condition sufficient to in-
crease RND 2 expression. In addition, a strong increase
of RND 2 expression was detected in the strain
D4(pEP_RND2_operon) (2·10−5 normalized copies)
(Fig. 2), consistent with the finding that this strain re-
acquired resistance to some of the antibiotics tested.
The extra-copies of the RND 2 operon in J2315 in-
creased the expression of both RND 4 (6·10−4 normal-
ized copies) and RND 2 (4·10−5 normalized copies);
apparently, this should result in a higher degree of resist-
ance to antibiotics. However, the strong increase of RND
2 expression was masked by the presence of RND 4 ef-
flux pump, which was the main one responsible for the
resistance to the antibiotics tested. The addition of
extra-copies of RND 4 to J2315 did not significantly in-
crease the expression of RND 4 (1·10−4 normalized cop-
ies) nor RND 2 (6·10−7 normalized copies).
Spontaneous mutants with high antibiotic resistance can
be obtained from the D4 strain through directed
evolution experiments
The ability of RND 2 to partially replace the activity of
the RND 4 operon through an increase in expression
suggests that under selective pressure it should be pos-
sible to isolate spontaneous mutants of strain D4 with
MIC values similar to those of strain D4(pEP_RND2_o-
peron). Therefore, we set up a directed evolution
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experiment with the B. cenocepacia D4 strain to obtain
spontaneous mutants resistant to sublethal concentra-
tions of chloramphenicol (one of the antibiotics that is a
substrate of both RND pumps). Two spontaneous mu-
tants, D4/C18 and D4/C20, were obtained after 15 days
in the presence of chloramphenicol. These mutants were
examined for antimicrobial resistance and the MIC
values against different antibiotics for the two mutants
were similar (Table 2). Increased resistance against
chloramphenicol and novobiocin compared to both D4
and J2315 was observed. For quinolones/fluoroquino-
lones the behavior was different depending on the anti-
biotic: nalidixic acid, ciprofloxacin, levofloxacin and
norfloxacin had MIC values higher than that of original
D4 strain and similar to those of J2315 strain, while
sparfloxacin resistance remained that of D4 strain.
Therefore, D4/C18 and D4/C20 showed increased mul-
tiple antibiotic resistance relative to D4 and not only re-
sistance to the antibiotic used for selection, suggesting
the activation of an efflux mechanism.
An insertion activates RND 2 expression in the D4/C18
and D4/C20 strains
RAPD fingerprinting analysis confirmed that the D4/
C18 and D4/C20 mutants had a profile identical to D4,
confirming their clonality (data not shown). We then ex-
tracted and sequenced the genomic DNA of strains D4,
D4/C18, and D4/C20 to identify the mutation(s) arising
under selective pressure (Additional file 5). The genome
sequences of the two mutants were compared to those
of D4 and J2315 for the presence of SNPs and/or large
insertions/deletions. No SNPs were found in the two
Table 1 Plasmids and strains used in this work
Strain or Plasmid Description Souce or
reference
Plasmids Vector Insert cloned Insert leight (bp) Characteristic/genotype
pGEM-T Easy Vector for PCR cloning,
Ampr
Promega
pRK2013 oricolE1, RK2 derivative,
Kanr, mob+, tra+
Figurski et al. 1979
pSCrhaB2 oripBBR1 rhaR rhaS PrhaB
Tpr mob+
Cardona et al.
2005
pEP_RND2_operon pSCrhaB2 Operon RND_2 (promoter
region,BCAS0766–64)
6178 Tpr This work
pEP_RND4_operon pSCrhaB2 Operon RND_4 (promoter
region, BCAL2822–20)
6288 Tpr This work
Strains Description Accession number
Escherichia coli
DH5α F− Φ80dlacZΔMI5 Δ(lacZYA-argF)U169
endA I recA I hsdRI7(rK
−mk
+) sup E44 thi-I
ΔgyrA96 relA I
Laboratory stock,
Bethesda Research
Laboratories 1986
SY327 araD Δ(lac pro) argE(Am) recA56 nalA
λ pir; Rifr anche pRK2013
Miller et al. 1988
SY327 (pRK2013, pEP_
RND2_operon)
This work
SY327 (pRK2013, pEP_
RND4_operon)
This work
Burkholderia cenocepacia
J2315 CF clinical isolate G. Manno, Buroni
et al. 2009
D4 J2315 ΔBCAL2820–BCAL2822 SRR3736982 Buroni et al. 2009
J2315 (pEP_RND2_operon) This work
J2315 (pEP_RND4_operon) This work
D4 (pEP_RND2_operon) This work
D4 (pEP_RND4_operon) This work
D4/C_18 D4 derivative, obtained in the presence
of Chloramphenicol
SRR3737008 This work
D4/C_20 D4 derivative, obtained in the presence
of Chloramphenicol
SRR3737019 This work
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mutants at the whole genome level, but several deletions
and insertions of different size were detected (Table 3).
The only mutation common to the D4/C18 and D4/C20
strains, associated with the common phenotype, is a
1300-bp insertion at position 867,051 of chromosome 3,
confirmed by PCR and DNA sequencing. This fragment
carries predicted transposase and integrase genes both
present on chromosome 1 (BCAL2755 = QU43_RS50390
and BCAL2756 = QU43_RS50395) and chromosome 2
(BCAM1929 = QU43_RS63980 and BCAM1930 =
QU43_RS63985) of J2315. The insertion is located
116 bp upstream of the araC family transcriptional regu-
lator gene (BCAS0768 = QU43_RS72510) and oriented
in the same direction, and 482 bp upstream of the lysR
family transcriptional regulator gene (BCAS0767 =
QU43_RS72500), oriented divergently. These two genes
encode regulatory proteins that are associated in the
genome with the RND 2 operon. Such genes could be
involved in its regulation of expression. To check the
possible effects of this insertion on the surrounding
genes, the expression levels of both genes and of the
RND 2 coding gene were evaluated in D4, D4/C18 and
D4/C20 strains (Fig. 3). In both D4/C18 and D4/C20 the
expression of the araC regulator gene was double that
of D4, while the expression of both the lysR regulator
and RND 2 genes increased significantly (t-test,
p < 0.05). We concluded that the increased resistance
observed in D4/C18 and D4/C20 was due to increased
RND 2 operon expression.
Discussion
We investigated how paralog RND operons could have
evolved and functionally diversified, and how these
events could influence the onset of novel resistance phe-
notypes. The search for RND 2 and RND 4 operons in
797 Burkholderia genomes revealed that the RND 4 op-
eron is highly conserved, being present in almost all the
genomes examined. The high conservation of RND 4 is
Fig. 2 Expression levels of RND 2- RND 4 genes in the B. cenocepacia J2315, D4, D4(pEP_RND2_operon), D4(pEP_RND4_operon), J2315(pEP_RND2_
operon), and J2315(pEP_RND4_operon) strains. The quantity mean of RND 2-RND 4 mRNA /quantity mean of the 16S rRNA gene in the presence of
4 μg/ml of nalidixic acid in the B. cenocepacia J2315, D4, D4(pEP_RND2_operon), D4(pEP_RND4_operon), J2315(pEP_RND2_operon), and
J2315(pEP_RND4_operon) strains are reported. The mean quantity of mRNA was estimated on the basis of the standard curve and for each
target gene it was normalized on the mean quantity of 16S rRNA, used as a reference. The differences in genes expression was assessed using
a t-test (* = P < 0.05)
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consistent with the critical role of this operon in mul-
tiple antibiotic resistance, virulence, and other cellular
processes [23–26, 28]. Further, a gene encoding a TetR
family transcriptional regulator located upstream of
RND 4 is highly conserved, suggesting that regulatory el-
ements controlling the RND 4 operon expression are
also common to all Burkholderia species.
In contrast, the RND 2 operon is only found in a few
Bcc species and likely resulted from a duplication event
of the entire RND 4 operon. The conclusion that RND 2
originated by a duplication of RND 4 and not by dupli-
cation of other RND operons sharing the very same gene
organization [20] is supported by the high degree of se-
quence identity between RND 2 and RND 4, which is
Fig. 3 Expression levels of RND 2, araC and lysR genes in the D4, D4/C18 and D4/C20 strains. The quantity mean of target gene mRNA / quantity
mean of 16S rRNA in the B. cenocepacia D4, D4/C18 and D4/C20 strains grown in LB medium are reported. The mean quantity of mRNA was
estimated on the basis of the standard curve and for each target gene it was normalized on the mean quantity of 16S rRNA, used as a reference.
The differences in genes expression was assessed using a t-test (* = P < 0.05)
Table 3 Mutations identified in B. cenocepacia D4/C18 and D4/C20 strains
Strain Mutations
B. cenocepacia D4/C18 Chromosome Size (bp) Position Genes lost/gained
Deletions 1 2439 From 188,010 to 190,448 BCAL0165, partial BCAL0166
1 12,975 From 191,455 to 204,429 Partial BCAL0167, BCAL0168–0182
2 2953 From 2,092,046 to 2,094,998 Partial BCAM1875, BCAM1876, BCAM1876a, Partial BCAM1877
Insertions 1 354 3,135,829 Part of the BCAL2854
3 320 867,051 Partial BCAL2755, inserted up to BCAS0768
B. cenocepacia D4/C20 Chromosome Size (bp) Position Genes lost
Deletions 1 2282 From 188,010 to 190,291 BCAL0165
1 12,744 From 191,686 to 204,429 Partial BCAL0167, BCAL0168–0182
1 82 From 1,417,069 to 1,417,150 Partial BCAL1303
1 10,944 From 1,426,727 to 1,437,670 Partial BCAL1308, BCAL1315–17
1 197 From 3,554,574 to 3,554,770 No coding region between BCAL3245 and BCAL3246
3 26,613 From 8888 to 35,500 Partial BCAS0007, BCAS008–0031
3 79,445 From 493,762 to 573,206 BCAS0421–0503
Insertions 3 886 867,051 Partial BCAS2756 and partial BCAL2755, inserted up to BCAS0768
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much higher than those existing between RND 2 or
RND 4 and the other RND operons. Lastly, the phylo-
genetic distribution of RND 2 operon allowed us to map
the putative duplication event inside the Bcc group
(Fig. 1b).
The RND 2 operon has retained most of the ancestral
substrate specificity, in that it maintained the ability to
extrude the same antimicrobial compounds extruded
by RND 4. This hypothesis is supported also by the
ability of RND 2 to restore the resistance to some anti-
biotics in the D4 mutant. However, the recovery of re-
sistance required overexpression of RND 2, that can be
obtained either by introducing extra-copies of RND 2
or by mutations altering its regulation. Confirming this
scenario, qRT-PCR experiments revealed that RND 2 is
expressed at very low level in LB medium even in the
presence of a possible inducer, in both B. cenocepacia
J2315 and the D4 mutant. The need for extra-copies of
the RND 2 operon in the D4 mutant or of a mutation
to increase the expression of the RND 2 operon sug-
gests that antibiotics are not the stimulus that leads to
the activation RND 2. According to these hypothesis,
different expression “circuits” should control the two
operons. From an evolutionary viewpoint, this means
that the duplication of the RND 4 operon also involved
parallel or subsequent genetic rearrangements resulting
in new regulatory elements (e.g. promoters) located up-
stream of the MFP gene of the RND 2 operon (subfunc-
tionalization) (Fig. 4). This new regulatory control may
have involved the appearance of two new genes, encod-
ing AraC-like and LysR-type regulators, respectively
(Fig. 1a). These two genes are present in all genomes
harboring an RND 2 operon, except for B. diffusa
(Fig. 1b). This suggests that the molecular rearrange-
ments that led to the localization of these two genes
close to the RND2 operon, might have occurred after
the duplication event, since B. diffusa is phylogenetic-
ally located at the base of the cluster in which the du-
plication occurred (Fig. 1b). The origin of these two
genes is still unclear. Searches carried out in all the
available prokaryotic genomes did not retrieve any se-
quence with a degree of identity/similarity sufficiently
high to suggest a common origin. Regardless, this regu-
latory circuit, once acquired, has been maintained,
since the two regulatory genes are present and in the
same order in all genomes harboring an entire RND 2
operon.
Expression data shed light on the regulation of the
RND 2. In the presence of extra copies of RND 2, sup-
plied by the recombinant plasmid pEP_RND2_operon,
the expression of RND 2 in J2315 (pEP_RND2_operon)
strain is higher than that in the parental strain. A plaus-
ible scenario could be that a constitutively expressed re-
pressor controls the RND 2 operon. We can then
hypothesize that when extra copies of the RND 2 operon
are present, the repressor concentration might be not
sufficient to block RND 2 expression. Accordingly, mu-
tations increasing the expression of a regulator gene
would have similar effects. This hypothesis was sup-
ported by the results from the directed evolution experi-
ments. In fact, increased RND 2 expression was parallel
to a strong increase of the associated lysR gene expres-
sion. Also, the gene encoding the AraC-type protein
might play a role in the RND 2 expression, since the ex-
pression of this gene increases in both mutants D4/C18
and D4/C20.
Fig. 4 Possible evolutionary pathway leading to the RND 2 and RND 4 operons in Bcc strains
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In summary, our results show that the Bcc RND 2 op-
eron most likely arose from a duplication of the RND 4
operon, but although RND 2 retains almost the same
functions in antibiotics extrusion as RND 4, its expres-
sion in Burkholderia cells is much lower. Therefore, a
different local mechanism regulating the expression of
the RND 2 operon suggests that changes in regulatory
circuits (rather than functional mutations) may influence
the role of different RND paralogs. Interestingly, the fact
that the RND 2 operon is encoded by B. cenocepacia
J2315 chromosome 3 further supports the subfunctiona-
lization hypothesis concerning the evolution of these
two efflux systems. Chromosome 3 is a megaplasmid en-
coding several critical features for pathogenicity and
chronic infection, but dispensable for bacterial viability
in vitro [31, 32]. This agrees with the notion that the
RND 2 operon is not completely diversified from its
homolog operon (i.e. RND 4), and consequently, it is not
yet essential for B. cenocepacia cells. It is plausible that
the RND 2 operon may be required only under certain
conditions related to chronic infection. Our directed evo-
lution experiment demonstrated that under selective pres-
sure, mutations may arise that rewire the local regulatory
circuit of the RND 2 operon, allowing it to respond to the
presence of antibiotics. A similar mechanism was identi-
fied in E. coli cells responding to osmotic stress [33], sug-
gesting that expression rewiring is an evolutionary answer
to stress conditions in bacteria.
Conclusions
Our study contributes to an explanation of how bacterial
regulatory networks can evolve to allow partial func-
tional diversification of paralogous genes, thus becoming
key players in maintaining a high genomic (and conse-
quently phenotypic) plasticity. Understanding the regula-
tory network underpinning the expression of the RND
multimeric complexes in Bcc can add new information
explaining the evolution of drug resistant phenotypes
and also potentially new strategies for their control.
Methods
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this work are
listed in Table 1. Bacteria were grown under aerobic
condition at 37 °C in Luria-Bertani (LB) agar or broth.
Antibiotic concentration used were 100 μg/ml ampicil-
lin, 50 μg/ml and 50 or 100 μg/ml trimethoprim for E.
coli and B. cenocepacia, respectively. Both antibiotics
were purchased from Sigma-Aldrich S.r.l.
Strains construction
The genome sequence of B. cenocepacia J2315 available
from GenBank database (GCA_000009485.1) [22], was
used for primers design. Due to their high size and GC
content, the two RND operons, RND 2 (old locus tags:
BCAS0764–BCAS0766, new locus tags: QU43_RS72485,
QU43_RS72490, QU43_RS72495) and RND 4 (old locus
tags: BCAL2820–BCAL2822, new locus tags: QU43_
RS50715, QU43_RS50720, QU43_RS50725), were cloned
using a two-step strategy. Firstly, a unique restriction
site (BamHI for operon RND 2 and KpnI for operon
RND 4) was identified in the sequences of the two op-
erons. In this way, the two operons were split into two
parts, and two divergent primers (R2_1/F2_2 and R4_1/
F4_2 for operon RND 2 and RND 4 respectively,
Additional file 6) were designed in correspondence of
these two restriction sites. Then, for each operon a for-
ward primer for the amplification of the first part of the
operon (including the putative promoter region) and a
reverse primer for the amplification of the second part
of the operon (including the putative transcription ter-
minator regions) were designed (Additional file 6). These
primers contained the restriction sites necessary for the
subsequent recovery of the operon (in both cases an
NdeI and HindIII restriction site were introduced in the
forward and reverse primers, respectively). The primer
pair F2_1/R2_1 was used to amplify a fragment of
3479 bp containing the putative promoter region of op-
eron RND 2, the gene coding for the MFP (BCAS0766,
QU43_RS72495) and a portion of the RND protein-
encoding gene (BCAS0765, QU43_RS72490). The primer
pair F2_2/R2_2 allowed for the amplification of a
2699 bp fragment containing the second half of the
RND coding gene (BCAS0765, QU43_RS2490) and the
OMP coding gene (BCAS0764, QU43_RS72485). For the
RND 4 operon, the primer pair F4_1/R4_1 was used to
amplify a 1937 bp fragment containing the putative pro-
moter region, the MFP coding gene (BCAL2822,
QU43_RS50725) and the first half of the RND protein-
encoding gene (BCAL2821, QU43_RS50720). The primer
pair F4_2/R4_2 for the amplification to a 4351 bp frag-
ment containing the second half of the RND coding
gene (BCAL2821, QU43_RS50720) and the OMP coding
gene (BCAL2820, QU43_RS50715).
PCR amplification of each region was performed in a
50 μL reaction mixture containing an aliquot of 2 μL of
purified DNA [prepared employing the NucleoSpin® Tis-
sue extraction kit (MACHEREY-NAGEL GmbH & Co.
KG) following the manufacturer’s instructions], 10 μL of
5X reaction buffer (5X Phusion HF Buffer, Thermo
Fisher Scientific), 0.5% DMSO, 0.5 μM of each primer,
200 μM dNTPs and 1 U of Taq DNA polymerase (Phu-
sion High-Fidelity DNA Polymerase, Thermo Fisher Sci-
entific). In order to reduce the number of non-specific
PCR products, an amplification program with several in-
creasing annealing temperatures was used [34]. For the
two primer pairs F2_1/R2_1 and F2_2/R2_2, cycle condi-
tion were 98 °C for 3′, followed by 30 cycles of 98 °C for
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45″, 60 °C for 45″, 62.5 °C for 45″, 65 °C for 45″, 67.5 °
C for 45″, 70 °C for 45″, 72 °C for 2′, and a final exten-
sion of 10′ at 72 °C. For the primer pair F4_1/R4_1 cycle
condition were 98 °C for 3′, followed by 30 cycles of 98 °
C for 45″, 67.5 °C for 45″, 70 °C for 45″, 72 °C for 1′,
and a final extension of 10′ at 72 °C. For the primer pair
F4_2/R4_2 cycling conditions were 98 °C for 3′, followed
by 30 cycles of 98 °C for 45″, 65 °C for 45″, 72 °C for 2′
and 30″, and a final extension of 10′ at 72 °C. Amplifi-
cation products were loaded on 0.6% agarose gels and
amplicons were excised from agarose gel and purified
using the MinElute gel extraction kit (Qiagen) according
to the manufacturer’s instructions.
Then, 3′ A-overhangs were added to the four purified
PCR products, in order to permit their insertion into the
appropriate plasmid cloning vector (see below). To this
purpose, 0.2 mM dATP, 1X reaction buffer (10X Dream-
Taq Buffer, Thermo Fisher Scientific) and 2 U of Taq
polymerase (DreamTaq DNA Polymerase, Thermo
Fisher Scientific) were added to the purified DNA in a
final volume of 10 μl, and incubated for 20′ at 72 °C.
After that, the four amplicons were cloned into the
pGEM®-T Easy Vector (Promega), using the manufacturer’s
instructions. The obtained plasmids (Additional file 7) were
introduced into E. coli DH5α by electroporation [35]. The
integrity of the cloned fragments was verified by sequen-
cing of the plasmids at the Genechron laboratory (Ylichron
Srl, Italy) using the primers reported in Additional file 6.
The entire RND 2 and RND 4 operons were then as-
sembled in the pSCrhaB2 vector [30]. First the two plas-
mids pGEM_RND2_second_part and pGEM_RND4_
second_part (Additional file 7) were digested with
BamHI-HindIII and KpnI-HindIII, respectively. The ob-
tained fragments, corresponding to the second parts of
the two operons, were ligated into the BamHI-HindIII
and KpnI-HindIII digested pSCrhaB2, respectively, to
yield the pEP_RND2_second_part and pEP_RND4_se-
cond_part plasmids (Additional file 7). Then, the two
plasmids pGEM_RND2_first_part and pGEM_RND4_-
first_part (Additional file 7) were digested with NdeI-
BamHI and NdeI-KpnI, respectively, and the obtained
fragments were ligated into the NdeI-BamHI and NdeI-
KpnI digested pEP_RND2_second_part and pEP_RND4_
second_part, respectively, to obtain the pEP_RND2_o-
peron and pEP_RND4_operon plasmids (Table 1 and
Additional file 7). All the restriction enzymes were
purchased from Fermentas (Thermo Fisher Scientific),
while for the ligation reactions the T4-DNA ligase in-
cluded in the pGEM®-T Easy Vector kit (Promega)
was used.
The two plasmids pEP_RND2_operon and pEP_RN-
D4_operon were introduced in E. coli SY327 [36] by
electroporation [35] and then mobilized into B. cenoce-
pacia J2315 by triparental mating, using the helper
plasmid pRK2013 [37, 38]. The presence of plasmids in
the final strains was controlled.
MIC determination
The MIC of different classes of antibiotics were deter-
mined: fluoroquinolones (ciprofloxacin, levofloxacin,
norfloxacin, sparfloxacin, nalidixic acid), aminoglyco-
sides (kanamycin), ansamycins (streptomycin), β-lactams
(ampicillin), macrolides (erythromycin), tetracycline, ri-
fampicin, chloramphenicol, gramidicin and novobiocin.
All the antibiotics were purchased from Sigma-Aldrich
S.r.l..
The MIC determination protocol was adapted from
Ulrich et al. [39]. Briefly, an Over-Night (ON) culture in
LB broth (and trimethoprim 50 μg/ml for strains carry-
ing plasmids) of each strain was diluted to a concentra-
tion of about 106 CFU/ml. In each well of a 96-well
plate, 50 μl of these bacterial suspensions were added to
plate wells containing LB medium with the appropriate
concentration of antibiotics (and trimethoprim at a final
concentration of 50 μg/ml for strains carrying plasmids)
to obtain a final bacterial concentration of about 5 × 104
CFU/well. Plates were incubated for 48 h at 37 °C static-
ally and MICs determined both visually and based on
the OD600 using a Tecan Infinite M200 plate reader
(Tecan, San Jose, CA). All MICs were determined in
triplicate, and the MIC was defined as the lowest con-
centration of antibiotics that prevented any detectable
growth.
RNA extraction and reverse transcription
B. cenocepacia strains J2315, D4, D4(pEP_RND2_o-
peron), D4(pEP_RND4_operon), J2315(pEP_RND2_o-
peron), and J2315(pEP_RND4_operon) were grown in
LB broth in the presence of 4 μg/ml of nalidixic acid
(half the MIC of the D4 strain), and trimethoprim
50 μg/ml for strains carrying plasmids, until an OD600 ~
0.5–0.6. 500 μl of each culture were treated with the
RNA protect bacteria reagent (Qiagen) and total RNA
was extracted using the RNeasy Mini Kit (Qiagen), using
the manufacturer’s instruction. DNA was removed from
the sample using the RNase-free DNase set (Qiagen).
Extracted RNA was reverse-transcribed using the
Superscript II Reverse Transcriptase (Invitrogen) and
Random primers (Invitrogen) following the manufac-
turer’s instruction.
B. cenocepacia D4, D4/C18 and D4/C20 strains were
grown in LB broth until an OD600 ~ 0.5–0.6 and RNA
was extracted and reverse-transcribed from 500 μl of
each of these cultures following the same procedure.
Quantitative real-time PCR (qRT-PCR)
qRT-PCR reactions were performed in 10 μl reaction
mixture containing an aliquot of 1 μl of cDNA, 5 μl of
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Maxima Syber Green/Rox qPCR Master Mix (2X) (Ther-
moScientific) and 1 μg/ml of each primer. For B. cenoce-
pacia J2315, D4, D4(pEP_RND2_operon), D4(pEP_
RND4_operon), J2315(pEP_RND2_operon), and J2315(pEP_
RND4_operon), each cDNA, amplification was carried out
using both the primer pairs RND_2_for/RND_2_rev and
RND_4_for/RND_ 4_rev (Additional file 6), while 16S RNA
encoding gene was used as reference. For the B. cenocepacia
D4, D4/C18 and D4/C20 strains amplifications were
performed using the three primer pairs RND_2_for/
RND_2_rev, BCAS0767_for/BCAS0767_rev and BCAS0768_
for/BCAS0768_rev (Additional file 6). The expression of
each gene in the mutant strain was compared with the ex-
pression of the same gene in the D4 strain; 16S RNA en-
coding gene was used as reference.
Each sample was spotted in triplicate and known
amounts of DNA of the B. cenocepacia J2315 strain (1–
0.1-0.01-0.001 ng) were added to obtain a standard
curve for each primer pairs. The reactions were per-
formed on a QuantStudio™ 7 Flex Real-Time PCR Sys-
tem (Applied Biosystems by Life Technologies). Cycling
conditions were: hold stage [50 °C for 2′ and 95 °C for
10′], PCR stage [40 cycles of: 95 °C for 30″, 57 °C or
60 °C for 30″ (57 °C for the primer pairs RND_2_for/
RND_2_rev and RND_4_for/RND_ 4_rev, 60 °C for
other pairs), 72 °C for 15″], melt curve stage [95 °C for
15″ and 60 °C for 1′].
Directed evolution experiment and mutants fingerprinting
B. cenocepacia D4 strain was grown ON (16 h) in LB
broth with shaking. 100 μl of this culture (~ 108–109
cells) and of a 10−1 dilution were plated on LB agar con-
taining different concentration of chloramphenicol (16,
32, 64, 128 μg/ml). All plates were checked every day,
for 15 days, and all of the colonies that grew, were fur-
ther selected on plates with 128 μg/ml chloramphenicol.
In this way 2 spontaneous resistant mutants selected on
chloramphenicol (named D4/C18 and D4/C20, Table 1)
were obtained.
A RAPD fingerprinting of B. cenocepacia D4 strain
and of the obtained spontaneous mutants was performed
as reported in Mocali et al. [40] using the primers 1253
[41] and AP5 [42].
DNA extraction and genome sequencing
Genomic DNA of B. cenocepacia D4, D4/C18 and D4/
C20 was extracted using the CTAB protocol previously
described in Perrin et al. [43]. Whole genome shot-gun
sequencing was performed by the Institute of Applied
Genomics and IGA Technology Services S.r.l. (University
of Udine, Italy) using an Illumina (Solexa) HiSeq2500.
The genome sequences determined are available in Gen-
Bank, accession numbers: B. cenocepacia D4 (SRR3736982),
B. cenocepacia D4/C18 (SRR3737008), B. cenocepacia D4/
C20 (SRR3737019).
Mutant validation
Deletions and insertions were confirmed by PCR ampli-
fication of the surrounding regions of the hypothetical
mutation using the primers reported in Additional file 6.
PCR amplifications were performed using the DreamTaq
DNA Polymerase (Thermo Fisher Scientific) in a 10 μl
reaction mixture containing 1 μl of same purified DNA,
1X reaction buffer, 0.5 μM of each primer, 200 μM
dNTPs and 2 U of Taq polymerase. Cycling condition
were: 95 °C for 3′, followed by 30 cycles of 95 °C for
10″, 60 °C for 30″, 72 °C for xx” (depending on the
size), and a final extension of 10′ at 72 °C.
Amplification products were purified as reported
above and sequenced at the Genechron laboratory
(Ylichron S.r.l., Italy).
Blast search of RND 2 and 4 operons
All the genomic sequences of Burkholderia representatives
available from GenBank (up to October 25th, 2016) were
downloaded using in-house bash scripts: 797 sequences
were obtained. When not present in GenBank, genome
annotation was obtained by applying the PROKKA [44]
annotation software to the genome sequence.
The amino acid sequences of RND 4 (gi:
206,561,158) and RND 2 (gi: 197,295,595) from B. cen-
ocepacia J2315 were used as queries for a blastp search
in all the accessions obtained. For each paralog, only
best hits with e-values <= 1e−15 were considered. In
this way, RND 2 and 4 coding genes were found in 47
and 689 of the genomes analyzed, respectively. Neigh-
boring coding DNA sequences (CDSs) were then com-
pared with the amino acid sequences of OMP and
MFP from B. cenocepacia J2315 (using blastp, consid-
ering only the best hits with e-value <= 1e−15) to iden-
tify the corresponding homologs in the target genome.
The entire RND 2 operon was found in 33 genomes,
while the entire RND 4 operon in 472 (Additional
file 3). The homologs of AraC (gi: 197,295,598), TetR
(gi: 206,561,160) and LysR (gi: 197,295,597) were found
in a similar way.
Sequencing reads analysis and variants calling
Reads quality was assessed using FastQC toolkit (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/).
Reads trimming was performed using the dynamic
trimming approach implemented in SolexQA [45],
using a Phred score of 20 as the base call quality
threshold. Trimmed reads were then mapped on the
reference genome using BWA with default parame-
ters. Only those SNPs that (i) were not present in the
WT strain, (ii) were supported by, at least, five reads,
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and (iii) had a support greater than 50% were consid-
ered for further analysis. SNPs calling was performed
using VarScan 2.4.0 [46]. Large variants (insertion and
deletion) calling was performed on the sorted BAM
file produced by BWA using Pilon 1.16 [47]. All SAM
and BAM files manipulation was performed using
SAM tools [48].
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